Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3300
0.00 (0.00%)
At close: Aug 7, 2026

Cleo Diagnostics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-4.03-4-3.76-1.73-0.08
Depreciation & Amortization
0.060.060.060.04-
Stock-Based Compensation
0.440.441.50.78-
Other Operating Activities
0.42--0.1700.08
Change in Accounts Receivable
0.020.02-0.01-0.03-
Change in Accounts Payable
0.560.560.020.37-
Change in Other Net Operating Assets
0.020.020.33-0.12-
Operating Cash Flow
-2.51-2.9-2.03-0.68-
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0.01-0.01-0-0.04-
Sale (Purchase) of Intangibles
----0.3-0.34
Investing Cash Flow
-0.01-0.01-0-0.34-0.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
---1.6-
Total Debt Issued
---1.60.42
Short-Term Debt Repaid
----0.2-
Total Debt Repaid
----0.2-
Net Debt Issued (Repaid)
---1.40.42
Issuance of Common Stock
5.01-12-0
Other Financing Activities
-0.37--0.83-0.18-
Financing Cash Flow
4.64-11.171.220.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
2.12-2.919.130.20.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-2.52-2.91-2.03-0.72-
Free Cash Flow Growth
-----
Free Cash Flow Margin
-98.35%-344.57%-964.47%--
Free Cash Flow Per Share
-0.02-0.02-0.02-0.03-
Levered Free Cash Flow
-1.25-1.46-0.4--
Unlevered Free Cash Flow
-1.25-1.46-0.38--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Change in Working Capital
0.60.60.340.22-